FREDUN PHARMACEUTICALS
Quarterly Results Analysis [Jun2026]
FREDUN PHARMACEUTICALS Quarterly Results
| Consolidated | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 Audited |
Sep2025 Audited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
|---|---|---|---|---|---|---|---|
| Revenues | ₹228 Cr | ₹213 Cr | ₹161 Cr | ₹145 Cr | ₹120 Cr | ₹167 Cr | ₹0 Cr |
| Expenses | ₹196 Cr | ₹184 Cr | ₹135 Cr | ₹123 Cr | ₹103 Cr | ₹150 Cr | ₹0 Cr |
| Operating Income | ₹33 Cr | ₹29 Cr | ₹26 Cr | ₹22 Cr | ₹17 Cr | ₹17 Cr | ₹0 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹9 Cr | ₹14 Cr | ₹11 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹0 Cr |
| Depreciation | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr |
| Profit Before Tax | ₹21 Cr | ₹11 Cr | ₹14 Cr | ₹13 Cr | ₹9 Cr | ₹7 Cr | ₹0 Cr |
| Profit After Tax | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹6 Cr | ₹0 Cr |
| EPS | ₹7.94 | ₹6.57 | ₹6.51 | ₹6.66 | ₹4.78 | ₹4.24 | ₹0.00 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FREDUN PHARMACEUTICALS | 1.1% | 35.7% | 292.9% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -1.4% | 21.7% |
| DIVIS LABORATORIES | 2% | 10.3% | 49.5% |
| TORRENT PHARMACEUTICALS | -0.4% | -0.5% | 38.6% |
| CIPLA | -0.5% | -2.5% | -10.2% |
| DR REDDYS LABORATORIES | -1.2% | 0% | -7.1% |
| MANKIND PHARMA | -1.5% | -3.3% | -4.6% |
| LUPIN | -0.6% | -9.4% | 13% |
| ZYDUS LIFESCIENCES | -3.2% | 2.9% | 19.2% |
FREDUN PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 7.13 % |
| Y-o-Y | 90.44 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹228 Cr | 7.13 | |
| Mar2026 | ₹213 Cr | 32.40 | |
| Dec2025 | ₹161 Cr | 10.76 | |
| Sep2025 | ₹145 Cr | 21.22 | |
| Jun2025 | ₹120 Cr | -28.41 | |
| Mar2025 | ₹167 Cr | 0 | |
| Dec2024 | ₹0 Cr | - | |
FREDUN PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 13.35 % |
| Y-o-Y | 92.69 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹33 Cr | 13.35 | |
| Mar2026 | ₹29 Cr | 9.68 | |
| Dec2025 | ₹26 Cr | 17.94 | |
| Sep2025 | ₹22 Cr | 31.42 | |
| Jun2025 | ₹17 Cr | -1.51 | |
| Mar2025 | ₹17 Cr | 0 | |
| Dec2024 | ₹0 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 5.75 % |
| Y-o-Y | 1.13 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 14.34% | 5.75 | |
| Mar2026 | 13.56% | -17.11 | |
| Dec2025 | 16.36% | 6.44 | |
| Sep2025 | 15.37% | 8.39 | |
| Jun2025 | 14.18% | 37.54 | |
| Mar2025 | 10.31% | 0 | |
| Dec2024 | 0% | - | |
FREDUN PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 21.82 % |
| Y-o-Y | 94.10 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹13 Cr | 21.82 | |
| Mar2026 | ₹11 Cr | 2.88 | |
| Dec2025 | ₹10 Cr | 11.08 | |
| Sep2025 | ₹9 Cr | 39.42 | |
| Jun2025 | ₹7 Cr | 12.69 | |
| Mar2025 | ₹6 Cr | 0 | |
| Dec2024 | ₹0 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 13.64 % |
| Y-o-Y | 1.95 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 5.75 % | 13.64 | |
| Mar2026 | 5.06 % | -22.27 | |
| Dec2025 | 6.51 % | 0.31 | |
| Sep2025 | 6.49 % | 15.07 | |
| Jun2025 | 5.64 % | 57.10 | |
| Mar2025 | 3.59 % | 0 | |
| Dec2024 | 0 % | - | |
FREDUN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 20.85 % |
| Y-o-Y | 66.11 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹7.94 | 20.85 | |
| Mar2026 | ₹6.57 | 0.92 | |
| Dec2025 | ₹6.51 | -2.25 | |
| Sep2025 | ₹6.66 | 39.33 | |
| Jun2025 | ₹4.78 | 12.74 | |
| Mar2025 | ₹4.24 | 0 | |
| Dec2024 | ₹0 | - | |
You may also like the below Video Courses